Updated Warfarin Label Notes Genetics’ Impact On Dosing, But Avoids Recommending Test

FDA adds pharmacogenetic information to warfarin label, says more specific recommendations on genetic testing and appropriate dosing await further studies.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet